Skip to main content
. 2023 Aug 30;13:14237. doi: 10.1038/s41598-023-41030-7

Figure 2.

Figure 2

Change in miRNAs levels with 5-FU-based therapy in CRC patients at baseline, and after 3 and 6 months of treatment. (A) in responders (n = 23), (B) in non-responders (n = 20). I. miRNA223-3p, II. miRNA20a.5p, III. miRNA17-5p, IV. miRNA19a-3P, V. miRNA7-5p. The levels of miRNAs are expressed as log2ΔΔCT, and P-values are displayed in the figures.